Jpmorgan Chase & CO Cardiovascular Systems Inc Transaction History

Jpmorgan Chase & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	BUY	$13.31 - $19.86 $689,458 - $1.03 Million	51,800 Added 17.73%	344,024 $6.83 Million
Q1 2023 May 11, 2023	SELL	$13.31 - $19.86 $475,167 - $709,002	-35,700 Reduced 10.89%	292,224 $5.8 Million
Q4 2022 Feb 13, 2023	SELL	$12.74 - $15.12 $305,237 - $362,260	-23,959 Reduced 6.81%	327,924 $4.47 Million
Q3 2022 Nov 14, 2022	SELL	$12.93 - $17.17 $178,162 - $236,585	-13,779 Reduced 3.77%	351,883 $4.88 Million
Q2 2022 Aug 11, 2022	SELL	$13.53 - $23.34 $135,218 - $233,259	-9,994 Reduced 2.66%	365,662 $5.25 Million
Q1 2022 May 11, 2022	SELL	$16.14 - $22.6 $2.07 Million - $2.9 Million	-128,270 Reduced 25.45%	375,656 $8.49 Million
Q4 2021 Feb 10, 2022	SELL	$18.64 - $36.77 $416,324 - $821,257	-22,335 Reduced 4.24%	503,926 $9.46 Million
Q3 2021 Nov 12, 2021	BUY	$32.83 - $43.0 $17.3 Million - $22.6 Million	526,261 New	526,261 $17.3 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.